Anduril Hit $61 Billion. The Compounding That Matters Isn't the Valuation.
Defense tech just set a funding record. Watch the production curve, not the cap table.
Anduril was worth $8.5 billion in 2022. Last month it raised at $61 billion. That’s roughly a double every year for four years straight. Compounding like that grabs all the attention. It’s also the part you should worry about least.
Here’s the news. Anduril closed a $5 billion Series H at a $61 billion valuation, led by Thrive Capital and Andreessen Horowitz. That doubles its $30.5 billion mark from June 2025, which had doubled the $14 billion from 2024. Revenue doubled too, to $2.2 billion in 2025.
It’s not alone. In March, Saronic, which builds autonomous ships, raised $1.75 billion at a $9.25 billion valuation led by Kleiner Perkins, more than doubling its price in about 13 months. Shield AI raised $1.5 billion at $12.7 billion earlier this year. Defense startups have announced more than 100 venture rounds in 2026 already, an all-time record pace per Crunchbase. Read the headlines and the story is “defense tech is hot.” True, but shallow.
The mental model is compounding. Most people think compounding is a number getting big fast. It’s really about a base that builds on itself, where this year’s output becomes next year’s input. The magic isn’t the growth rate. It’s that the gains don’t reset.
So look again. Anduril’s valuation is compounding, sure. But the company is reportedly taking around a $1.2 billion operating loss this year on purpose, pouring capital into factories: Arsenal-1 in Ohio, a new campus in Long Beach, a rocket-motor plant in Mississippi. Saronic is doing the same with its Louisiana shipyard and a next-gen facility called Port Alpha, aiming for 20-plus ships a year by 2027 and sitting on a $392 million Navy contract. That’s the compounding that actually matters. Production capacity, contracts, clearances, manufacturing yield. Each factory makes the next contract easier to win. Each contract funds the next factory.
The valuation curve is the fast compounder. The capacity curve is the slow one. They look similar on a chart today. They behave nothing alike under stress.
I watch this category closely, partly because I still serve in the Reserve, and partly because at /mkt we live the same truth in a different domain. We build trading infrastructure for athlete tokenization under a Reg A+ framework on tZERO, and the compounding there isn’t the headline either. It’s trust, settlement, and compliance stacking quietly, year over year. You can’t raise your way to a compounded base. You have to build it.
Here’s the cold read. A valuation can halve in a quarter. A shipyard can’t. So if you want to know which of these companies is real, ignore the cap table and watch the capacity curve. Are the factories opening on schedule? Are the contracts compounding or just renewing? And watch the thing that could break the whole thesis: the Pentagon just spread a hypersonic missile deal across Anduril and three other firms, a quiet signal it won’t lock itself into any single rising star. If the contracts stop compounding, then the valuation was never compounding on a base. It was compounding on a story.
Fast curves impress. Slow curves survive. Bet on the one that doesn’t reset.
Figures above are sourced from public disclosures, company announcements, and press reporting, and may change. This newsletter is for informational and educational purposes only. It is not investment advice, and nothing here is a recommendation to buy, sell, or hold any security. Do your own work and talk to a licensed professional before making any financial decision.
If this was useful, share it with someone who builds things. And if you want the full toolkit of 50 mental models, my book is coming soon.